Skip to content
DemonstrationReset
Sign up
Your account
Reg CFTRL32.4–3.8Tier IOpen

Aurora Fusion Labs

Aurora Fusion Labs

A SAFE in a compact tokamak that has not yet reached scientific breakeven.

Rare-earth barium copper oxide superconductors allow a much higher magnetic field, and confinement improves steeply with field strength, which is why a compact machine is now arguable at all. Aurora has demonstrated a full-scale magnet at field and published the results. It has not produced net energy, and neither has anyone else in a commercial setting. This is one of the most speculative offerings on the platform and is priced accordingly at a $50 minimum.

Devens Research Campus · Devens, MANot applicableEscrow: Cadence Escrow Services
TRL 3 of 9, band 2.4 to 3.8, signed by Dr. Samuel Adeyemi, PhD Nuclear Engineering; ASME Section III reviewer, on Jun 19, 2026.See the evidence it rests on

$1,915,000 committed of $5,000,000

$287,250 released · 38% subscribed

Released to the issuerCommitted, held in escrowRemaining
Minimum
$50

$50 per unit

Instrument
SAFE
Term
None
Investors
2,047

Closes December 20, 2026 · 98 days remaining

Sign in to see your limit

  • Eligibility depends on residency, accreditation status and how much you have already invested this year.
  • You can read everything about this offering without an account. Committing capital requires one.
Open an account
Open an account to invest

Demo · viewing as

Browsing without an account. Everything is visible; nothing is purchasable until you verify who and where you are.

Or answer the questions yourself

No money will move

No payment processor is connected. The commitment flow runs end to end, through amount, agreement, signature and receipt, and records a simulated position rather than a charge.

Issuer updates

  1. Magnet results in the literature; next milestone is years out

    June 24, 2026

    The full-scale magnet result is published and the first tranche has been released at 15%. We want to set expectations honestly: the next milestone is first plasma, targeted for 2029, and the one after that is scientific breakeven. Nobody has done the third one commercially. Please read the risk factors.

    Tobias Lindqvist, Chief Scientist